YBX1 and neoplasm: Previous work in our lab showed that the serine/threonine kinase AKT phosphorylates, and thereby activates, YB-1 at S102 and that inhibiting this site disrupts nuclear trafficking [20], DNA binding [10] and tumour cell growth [20].